Proteomics International


Company Announcements:
(reported by the Company)
Elevator Pitch:

Proteomics International is a medical technology company specialising in providing sophisticated analytical services and developing new diagnostic tests for chronic diseases. The company’s core technology platform uses proteomics – the industrial-scale study of the structure and function of proteins. In 2015–16, PI grew its analytical services business in India, secured its first contracts in the Middle East, improved distribution channels in Japan and expanded into Central America. An ongoing partnership with InVentiv Health led to new market expansion opportunities in the US. Exports account for 40 per cent of PI’s total revenue.

Part of the PILL group.

Category: Health & biotech
URL: http://www.proteomics.com.au/
Operational Status: Active
ASX Listing Code (if applicable): PIQ
Year of Commencement: 2001
Address:

QEII Medical Centre
6 Verdun Street, Nedlands WA 6009
Australia

State: Western Australia
Overseas Operations: No
Twitter:
Facebook:
Linkedin: https://www.linkedin.com/company/proteomics-international
Key Personnel:
Validated Problem Solver Engagements:
No items found
Awards won:

WA Exporter of the Year 2016
WA Industry and Export Awards 2016 - Health and Biotechnology category
WA Industry and Export Awards 2015 - Health and Biotechnology category

Current Period Rank:



WA Annual Rank 2016: 66

Milestones:

    November, 2016

    Overall winner of WA Industry and Export Awards


    Signed production contract with Monash Antibody Technologies Facility to produce the custom antibodies needed for a multiplex ELISA


    October, 2016

    Appointed Roger Moore as a Non-Executive Director


Funding:

Company News:

NOTE: Company News, Milestones and Funding are as collected by Techboard as part of our Monthly Startup Ranking

Amount Seeking:
Type of capital raise:
Pre-money valuation:
ESIC Status:
ESIC Upload:
Future Intentions:
Investment Video:
Investment Pitchdeck:
Investment URL:
Investment Phone:
Investment Email:

Leave a Reply